What is it about?
This was the first randomised controlled trial of treatment for children with apraxia of speech (CAS). We compared two treatments - Rapid Syllable Transition Treatment (ReST) originally developed by Prof Donald A. Robin and the Nuffield Dyspraxia Programme 3rd Ed. from the UK. The children had normal receptive language skills and no other developmental diagnoses. While both groups improved, findings suggested ReST lead to better maintenance of improvements over time.
Featured Image
Photo by Steven Libralon on Unsplash
Why is it important?
This was the first randomised controlled trial of treatment for children with apraxia of speech (CAS).
Read the Original
This page is a summary of: A Randomized Controlled Trial for Children With Childhood Apraxia of Speech Comparing Rapid Syllable Transition Treatment and the Nuffield Dyspraxia Programme–Third Edition, Journal of Speech Language and Hearing Research, June 2015, American Speech-Language-Hearing Association (ASHA),
DOI: 10.1044/2015_jslhr-s-13-0179.
You can read the full text:
Resources
Contributors
The following have contributed to this page
